8 years ago

Antidote Technologies Secures $11 Million to Expand Clinical Trial Matching Platform

  • Antidote Technologies, a digital health company based in London and New York, has raised $11 million in funding

  • The round was led by Merck Global Health Innovation Fund (GHI), with participation from existing investors Smedvig Capital and Octopus Ventures

  • Antidote Technologies plans to use the funding to accelerate the development of new capabilities for its trial matching platform, including precision medicine and EHR-matching, as well as further global expansion

  • The company has created Antidote Match, a clinical trial matching platform that currently reaches millions of patients in more than 180 online communities.

      • ProblemHealthcare

      "connecting patients with relevant clinical trials"

      Solution

      "a digital platform that matches patients with clinical trials based on their health information"

      Covered on